about
A generic cycling hypoxia-derived prognostic gene signature: application to breast cancer profiling.Lectin chromatography/mass spectrometry discovery workflow identifies putative biomarkers of aggressive breast cancers.αB-crystallin, an effector of unfolded protein response, confers anti-VEGF resistance to breast cancer via maintenance of intracrine VEGF in endothelial cells.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gene profiling in breast cancer: time to move forward.
@en
Gene profiling in breast cancer: time to move forward.
@nl
type
label
Gene profiling in breast cancer: time to move forward.
@en
Gene profiling in breast cancer: time to move forward.
@nl
prefLabel
Gene profiling in breast cancer: time to move forward.
@en
Gene profiling in breast cancer: time to move forward.
@nl
P2093
P1476
Gene profiling in breast cancer: time to move forward
@en
P2093
Alvaro Pinto
Andrés Redondo
Enrique Espinosa
Iker Sánchez Navarro
Jaime Feliu
Juan Ángel Fresno Vara
Pilar Zamora
P304
P356
10.1016/J.CTRV.2010.12.009
P577
2011-02-01T00:00:00Z